Trials / Completed
CompletedNCT00697151
Patent Foramen Ovale in Cryptogenic Stroke Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 630 (actual)
- Sponsor
- Columbia University · Academic / Other
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study sought to assess the rate of recurrent stroke and death in stroke patients with a patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter study conducted at 48 U.S. Institutions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Warfarin | Warfarin once a day, titrated to obtain an INR of 1.4 to 2.8; placebo aspirin once a day |
| DRUG | Aspirin | Aspirin 325 mg once a day; placebo warfarin once a day |
Timeline
- Start date
- 1993-06-01
- Primary completion
- 2000-06-01
- Completion
- 2000-06-01
- First posted
- 2008-06-13
- Last updated
- 2011-09-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00697151. Inclusion in this directory is not an endorsement.